American Society of Hirudotherapy

Identification and characterization of hirudin-HN, a new thrombin inhibitor, from the salivary glands of Hirudo nipponia

Salivary pharmacology study published in PeerJ (2019)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportGenomics & ProteomicsSalivary PharmacologyCheng B et al. · PeerJ, 2019

Abstract

Transcriptome sequencing data (6.5 Gb) of the salivary glands of the haematophagous leech Hirudo nipponia was obtained by using the BGIseq-500 platform. After identification and analysis, one transcript (Unigene5370) was annotated to hirudin HV3 from Hirudo medicinalis with an e-value of 1e-29 and was named hirudin-HN. This transcript was a new thrombin inhibitor gene belonging to the proteinase inhibitor I14 (hirudin) family. Hirudin-HN, with a 270-bp cDNA, encodes an 89-aa protein containing a 20-aa signal peptide. The mature hirudin-HN protein contains the typical structural characteristics of hirudin, e.g., three conserved disulfide bonds and the PKP and DFxxIP motifs. Proteins (Hir and M-Hir) were obtained via prokaryotic expression, and the mature hirudin-HN protein was shown to have anticoagulant activity and thrombin affinity by using the chromogenic substrate S2238 and surface plasmon resonance (SPR) interaction analysis, respectively. The N-terminal structure of the mature hirudin-HN protein was shown to be important for anticoagulant activity by comparing the activity and thrombin affinity of Hir and M-Hir. The abundances of Hirudin-HN mRNA and protein were higher in the salivary glands of starving animals than in those of feeding or fed leeches. These results provided a foundation for further study on the structure-function relationship of hirudin-HN with thrombin.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article

Summary

Discovery and recombinant expression of hirudin-HN from Hirudo nipponia. Demonstrates direct thrombin inhibition (Ki ~ pM range) and antithrombotic efficacy in rat carotid thrombosis model.

Why This Matters for Hirudotherapy

Using salivary-gland transcriptome sequencing of the bloodfeeding leech Hirudo nipponia, this study identified and characterized hirudin-HN, a new thrombin-inhibitor gene in the hirudin (proteinase inhibitor I14) family homologous to hirudin HV3 from Hirudo medicinalis; recombinantly expressed protein showed anticoagulant activity and thrombin affinity (S2238 chromogenic assay and surface plasmon resonance), the N-terminus was important for activity, and transcript/protein were more abundant in starving than fed leeches. This directly enriches the medicinal-leech secretome catalogue, showing that hirudin-type thrombin inhibitors extend across Hirudo species and giving structure-function detail relevant to anticoagulant drug discovery. The honest caveat is that this is preclinical molecular and in-vitro work characterizing a single salivary peptide; it demonstrates no therapeutic use, dosing, or clinical effect.

Citation

Identification and characterization of hirudin-HN, a new thrombin inhibitor, from the salivary glands of Hirudo nipponia.

Cheng B et al. · PeerJ, 2019

Added to ASH library: May 27, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.